Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127543411 | 12754341 | 1 | I | 20160908 | 20160916 | 20160916 | EXP | PHHY2016TR125124 | NOVARTIS | YEKTAS C, CANSIZ MA, TUFAN AE.. INCREASED FREQUENCY OF ENCOPRESIS IN A CHILD DIAGNOSED WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER AND ENCOPRESIS AFTER ATOMOXETINE USE: A CASE REPORT. CLINICAL NEUROPHARMACOLOGY. 2016;39(4):212-3 | 11.00 | YR | M | Y | 0.00000 | 20160916 | OT | TR | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127543411 | 12754341 | 1 | PS | METHYLPHENIDATE. | METHYLPHENIDATE | 1 | Oral | 27 MG, QD | Y | 21278 | 27 | MG | QD | ||||||
| 127543411 | 12754341 | 2 | SS | METHYLPHENIDATE. | METHYLPHENIDATE | 1 | Oral | 36 MG, QD | Y | 21278 | 36 | MG | QD | ||||||
| 127543411 | 12754341 | 3 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 1 MG, QD | Y | 0 | 1 | MG | QD | ||||||
| 127543411 | 12754341 | 4 | SS | RISPERIDONE. | RISPERIDONE | 1 | Y | 0 | |||||||||||
| 127543411 | 12754341 | 5 | SS | ATOMOXETINE | ATOMOXETINE | 1 | Unknown | 18 MG, QD | Y | 0 | 18 | MG | QD | ||||||
| 127543411 | 12754341 | 6 | SS | ATOMOXETINE | ATOMOXETINE | 1 | Unknown | 40 MG, QD, 3-WEEK PERIOD | Y | 0 | 40 | MG | QD | ||||||
| 127543411 | 12754341 | 7 | SS | ATOMOXETINE | ATOMOXETINE | 1 | Unknown | 18 MG, QD | Y | 0 | 18 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127543411 | 12754341 | 1 | Attention deficit/hyperactivity disorder |
| 127543411 | 12754341 | 2 | Encopresis |
| 127543411 | 12754341 | 3 | Attention deficit/hyperactivity disorder |
| 127543411 | 12754341 | 4 | Encopresis |
| 127543411 | 12754341 | 5 | Attention deficit/hyperactivity disorder |
| 127543411 | 12754341 | 6 | Encopresis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127543411 | 12754341 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127543411 | 12754341 | Condition aggravated | |
| 127543411 | 12754341 | Drug effect incomplete | |
| 127543411 | 12754341 | Encopresis | |
| 127543411 | 12754341 | Enuresis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |